You're one step closer to unlocking our suite of comprehensive and robust tools.
Fill out the form so we can connect you to the right person.
Recent awards include:
If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at S&P Capital IQ Pro or S&P Capital IQ .
Ablynx establishes US subsidiary
S&P Capital IQ Pro | Unrivaled Sector Coverage
S&P Capital IQ Pro | Powering Your Edge
Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud
Investment Research Analysts Providing Greater Coverage on Inflation
Ablynx NV established Ablynx Inc., a subsidiary in the U.S.
Daniel Schneider will head the unit as general manager with the goal of commercializing caplacizumab in North America.
If approved by regulatory authorities, caplacizumab would be the first therapeutic specifically indicated to treat acquired thrombotic thrombocytopenic purpura.